RT Journal Article
SR Electronic
T1 Impact of COVID-19 on tuberculosis notifications in Blantyre Malawi: an interrupted time series analysis and qualitative study with healthcare workers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.15.21253601
DO 10.1101/2021.03.15.21253601
A1 Soko, Rebecca Nzawa
A1 Burke, Rachael M
A1 Feasey, Helena RA
A1 Sibande, Wakumanya
A1 Nliwasa, Marriott
A1 Henrion, Marc YR
A1 Khundi, McEwen
A1 Dodd, Peter J
A1 Ku, Chu Chang
A1 Kawalazira, Gift
A1 Choko, Augustine T
A1 Divala, Titus H
A1 Corbett, Elizabeth L
A1 MacPherson, Peter
YR 2021
UL http://medrxiv.org/content/early/2021/03/24/2021.03.15.21253601.abstract
AB COVID-19 may impact on tuberculosis (TB) diagnosis and care. We analysed a city-wide electronic TB register in Blantyre, Malawi and interviewed TB officers. Malawi had no official “lockdown” but closed schools and borders on 23-March 2020. In interrupted time series analysis, there was an immediate 35.9% reduction in TB notifications (95% CI 22.0 to 47.3%) in April, which recovered to near pre-pandemic numbers by December 2020, but with 333 (95% CI 291 to 375) fewer cumulative notifications than anticipated. Women and girls were impacted (30.7% fewer cases, 95% CI 28.4 to 33.0%) more than men and boys (20.9% fewer, 95% CI 18.5 to 23.3). Fear of COVID-19 infection, temporary facility closure, inadequate protective equipment and COVID-19 stigma with similar presenting symptoms to TB were mentioned. Public health measures could benefit both TB and COVID-19, but only if diagnostic services remain accessible and are considered safe to attend.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Blantyre Enhanced TB Surveillance data is funded by Wellcome, through a grant to ELC (200901/Z/16/Z). Wellcome had no role in design or conduct or this work, or the decision to publishAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:London School of Hygiene and Tropical Medicine Research Ethics Committee University of Malawi College of Medicine Research Ethics Committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code to recreate analyses are freely available at https://github.com/rachaelmburke/tbcovidblantyre https://github.com/rachaelmburke/tbcovidblantyre